Editorial


Is there a beneficial effect of adding azathioprine to adalimumab in Crohn’s disease patients?

Mark Löwenberg

Abstract

Crohn’s disease (CD) is a debilitating chronic inflammatory bowel disease that can affect any part of the gastrointestinal tract. The disease is characterized by transmural inflammation and typically has a relapsing course over time. Up to now, there is no curative treatment.

Download Citation